Skip to main content
Livermore
Livermore
ZHEN

AXA S.A.

SEC CIK
0000898427
Latest filing
Aug 14, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by AXA S.A., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of EW by AXA S.A., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−14,584−100.0%Sold outHolders
Q4 202514,584$1.24M0.6%−2,508−14.7%ReducedHolders
Q3 202517,092$1.33M0.7%−699,815−97.6%ReducedHolders
Q2 2025716,907$56.1M0.2%+71,796+11.1%AddedHolders
Q1 2025645,111$46.8M0.2%−46,851−6.8%ReducedHolders
Q4 2024691,962$51.2M0.2%−83,539−10.8%ReducedHolders
Q3 2024775,501$51.2M0.2%−227,001−22.6%ReducedHolders
Q2 20241,002,502$92.6M0.3%−373,433−27.1%ReducedHolders
Q1 20241,375,935$131.5M0.4%+7,173+0.5%AddedHolders
Q4 20231,368,762$104.4M0.3%−100,130−6.8%ReducedHolders
Q3 20231,468,892$101.8M0.4%−348,482−19.2%ReducedHolders
Q2 20231,817,374$171.4M0.6%+447,265+32.6%AddedHolders
Q1 20231,370,109$113.3M0.4%−40,971−2.9%ReducedHolders
Q4 20221,411,080$105.3M0.4%+223,287+18.8%AddedHolders
Q3 20221,187,793$98.1M0.4%−34,753−2.8%ReducedHolders
Q2 20221,222,546$116.3M0.4%−72,835−5.6%ReducedHolders
Q1 20221,295,381$152.5M0.4%−67,363−4.9%ReducedHolders
Q4 20211,362,744$176.5M0.5%−303,351−18.2%ReducedHolders
Q3 20211,666,095$188.6M0.5%+393,740+30.9%AddedHolders
Q2 20211,272,355$131.8M0.4%+53,019+4.3%AddedHolders
Q1 20211,219,336$102.0M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.